Eurand Pharma Ltd

1 medicine1 country

1 medicine in 1 country, as authorisation holder.

Group structure

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Every medicine in the registers under its name, current ones first.

1 medicine

Medicine	Substance	Country	Status	Authorised
ZENPEP105,000usp units; 25,000usp units; 79,000usp units \| 14,000usp units; 3,000usp units; 10,000usp units \| 168,000usp units; 40,000usp units; 126,000usp units \| 24,000usp units; 5,000usp units; 17,000usp units \| 252,600usp units; 60,000usp units; 189,600usp units \| 42,000usp units; 10,000usp units; 32,000usp units \| 63,000usp units; 15,000usp units; 47,000usp units \| 84,000usp units; 20,000usp units; · Capsule, delayed release	Pancrelipase (amylase, Lipase, Protease	United States	Marketed	2009

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.